Madrigal Eyes MASH Future As Rezdiffra Nears Blockbuster Revenue

 
• By Joseph Haas
  
Timeline stretching into sunset from 2026 to 2035
Nearing blockbuster sales with Rezdiffra, Madrigal has its eyes on the long-term MASH market (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business